Product Information
ABSORICA LD 32 MG CAPSULE is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $42.0658 per EA under NDC 10631000731. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the isotretinoin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
32 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
10631000731
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISOTRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA211913On Market Since
11/20/2019
Pharmacological Classes
Price Statistics
The NADAC for ABSORICA LD 32 MG CAPSULE has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $42.0658 per EA |
|---|---|
| All-time high | $42.4422 (Jan 15, 2025) |
| All-time low | $41.3154 (Aug 20, 2025) |
| 52-week high | $42.0658 |
| 52-week low | $41.3154 |
| Median price | $42.0149 |
| Average price | $42.0427 |
| Largest weekly change | -0.9% (Aug 20, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the isotretinoin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ABSORICA LD 32 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ABSORICA LD 32 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $42.0658 per EA (NDC 10631000731), effective Jun 24, 2026.
How has the price of ABSORICA LD 32 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ABSORICA LD 32 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ABSORICA LD 32 MG CAPSULE?
Since Apr 17, 2024, the NADAC for ABSORICA LD 32 MG CAPSULE has ranged from a low of $41.3154 (Aug 20, 2025) to a high of $42.4422 (Jan 15, 2025), with a median of $42.0149 per EA.
Are there cheaper alternatives to ABSORICA LD 32 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ABSORICA LD 32 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures ABSORICA LD 32 MG CAPSULE?
ABSORICA LD 32 MG CAPSULE (NDC 10631000731) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification